With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.
Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (316)
Press Release
Express Scripts Sues to Preserve Access to Care for Arkansans
May 29, 2025
Misguided new law will disrupt care for hundreds of thousands of patients, affect fertility treatments, and put Arkansans living with chronic diseases at risk of losing access to their medications.
Article
Evernorth Specialty Services patient spotlight: Dave
May 28, 2025
Meet Dave, an Accredo patient living with common variable immune deficiency (CVID). With the support of Accredo's specialized team, Dave is better enabled to live life on his own terms.
Article
Connecting members to latest breast cancer treatment
May 22, 2025
Learn why health plans need to stay informed on the most recent advancements, treatments and resources in breast cancer care for their members.
Article
Guiding a customer through extreme grief
May 22, 2025
Read the inspiring story of how Mary Beth Hull helped a customer navigate the overwhelming grief of losing a close family member.
Press Release
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
May 21, 2025
• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible
• New offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patients
Article
Most Favored Nation policy cannot succeed without the pharmacy benefit
May 20, 2025
Considering President Trump’s recent executive order, we examine the Most Favored Nation prescription drug pricing policy to the pharmacy benefit and discuss how removing PBMs – “the middleman” – is oversimplified and shortsighted.
